Quick Facts: Теопэк (Theophylline)

• Chronic Respiratory Conditions: Used to help manage symptoms associated with long-term lung diseases.
• Asthma: A maintenance treatment to support the management of chronic asthma.
• COPD: Utilized in the management of Chronic Obstructive Pulmonary Disease (COPD).
• Airway Support: Contributes to the relaxation of air passages in the lungs.

Теопэк, which contains the active ingredient theophylline, is a medication indicated for use in managing certain chronic respiratory conditions. It is primarily utilized as a long-term treatment option to support patients with chronic obstructive pulmonary disease (COPD) and asthma. The medication is intended to help relieve symptoms such as wheezing, chest tightness, and shortness of breath associated with these long-term lung disorders.

By influencing the muscles of the bronchial airways, this treatment works to open the air passages in the lungs, making breathing easier for the patient. Теопэк is typically considered an add-on therapy for individuals whose condition is not adequately controlled by other standard treatments. Patients should continue to use the medication exactly as prescribed by their healthcare professional as part of a complete management plan.

Теопэк (theophylline extended-release) is a medication used to treat conditions like asthma and Chronic Obstructive Pulmonary Disease (COPD). It is essential to understand who can and cannot safely use this drug, as it has a narrow therapeutic index, meaning the difference between a therapeutic and a toxic dose is small.

Who Should Not Use Теопэк?

This medication is generally contraindicated (should not be used) in patients with a known hypersensitivity or allergy to theophylline or other xanthine derivatives (such as caffeine or aminophylline).

Additionally, due to the potential for exacerbating certain conditions, its use is typically avoided or requires extreme caution and careful monitoring in the presence of:

• Active peptic ulcer disease
• Underlying seizure disorders
• Certain cardiac arrhythmias (irregular heart rhythms, excluding bradyarrhythmias)

Use with Caution

Other health issues require a doctor's careful assessment, as they may affect how the drug is processed or increase the risk of side effects. These include:

• Liver impairment (such as cirrhosis or acute hepatitis)
• Congestive heart failure
• Hyperthyroidism
• Age (infants under 1 year and adults over 60 may have altered drug clearance)

Factors like smoking tobacco, changes in diet, or the use of many other medications can also significantly change the theophylline level in the blood, necessitating dose adjustments and close medical supervision.

Теопэк Interactions with other medicines and products

Теопэк contains theophylline, a substance with a narrow therapeutic index, meaning that small changes in its concentration in the body can lead to a shift from therapeutic effects to potential toxicity. Due to this characteristic, theophylline is subject to numerous clinically significant interactions, primarily affecting its metabolism and clearance from the body.

---

Pharmacokinetic Interactions

1. Increased Theophylline Levels (Risk of Toxicity):

Interacting medicines that inhibit the liver enzyme CYP1A2 can decrease theophylline's clearance, potentially leading to toxic serum concentrations. Clinically significant examples include certain fluoroquinolone antibiotics (e.g., ciprofloxacin), macrolide antibiotics (e.g., erythromycin), cimetidine, and allopurinol.

2. Decreased Theophylline Levels (Risk of Reduced Efficacy):

Interacting medicines that induce CYP1A2 enzyme activity can increase theophylline's clearance, lowering its serum concentration and potentially reducing its effectiveness. Examples include phenytoin, carbamazepine, phenobarbital, and rifampicin. Smoking tobacco also significantly increases clearance and reduces theophylline levels.

---

Product and Substance Interactions

Substance Category	Effect on Theophylline	Interaction Relevance
Caffeine (coffee, tea, cola, chocolate)	Can increase side effects and toxicity.	Use with caution/Limit intake
Tobacco Smoke	Increases clearance, reducing effectiveness.	Dosage adjustment needed upon cessation
St. John's Wort	May decrease blood levels (via CYP induction).	Combination generally avoided

---

Clinical and Procedural Notes

Concurrent use of theophylline with other xanthine derivatives, such as caffeine, is generally discouraged due to the potential for additive central nervous system stimulation and toxicity. Patients initiating or discontinuing smoking, or starting or stopping any interacting medicine, require close monitoring of theophylline serum concentrations to prevent serious adverse events like seizures or cardiac arrhythmias.

The action of Теопэк (Choline Theophyllinate) is defined by its active ingredient, Theophylline, which uses three distinct, non-selective mechanisms to modulate both smooth muscle tone and inflammation at the cellular level.

Enzyme Inhibition and Airway Muscle Relaxation

This core mechanism involves the inhibition of Phosphodiesterase (PDE) enzymes, particularly PDE3 and PDE4. Blocking these enzymes prevents the breakdown of the signaling molecule cAMP, causing its levels to rise in the bronchial smooth muscle cells. This cascade directly results in the relaxation of the air passage muscles, which is the key physiological effect on airway diameter.

---

Receptor Blockade and Signaling Modulation

Theophylline also acts as a non-selective antagonist of Adenosine Receptors (e.g., A1, A2B). By occupying these sites, the drug prevents the natural chemical adenosine from binding, which in turn reduces the subsequent release of constrictive chemical mediators from cells like mast cells. This action modulates the signaling pathways that trigger acute narrowing, resulting in the modulation of the physiological response known as airway hyperresponsiveness.

---

Transcriptional Modulation of Inflammation

A third, distinct mechanism involves the enhancement of Histone Deacetylase 2 (HDAC2) activity and the inhibition of PI3K- delta . These actions target the molecular machinery within the cell nucleus, leading to the suppression of pro-inflammatory gene transcription. This mechanism results in the physiological suppression of pro-inflammatory gene expression pathways within the airways.

How to Use Теопэк (Theophylline) — Administration Guidelines

Теопэк, which contains the active ingredient Theophylline, is an extended-release medication used for long-term maintenance therapy. Its proper administration follows specific protocols to ensure consistent blood concentrations.

Administration and Dosage Format

Feature	Instruction
Route of Administration	Oral (PO) for maintenance therapy; Intravenous (IV) for acute loading doses.
Dosage Forms	Extended-release tablets and capsules (e.g., 12-hour or 24-hour).
ER Tablet/Capsule Rule	Must be swallowed whole; generally do not crush, chew, or break.
Timing with Meals	Should be taken consistently, either always with or always without food, as directed by the prescribing professional.

---

Standard Dosing and Adjustment Rules

Dosage is highly individualized and relies on measurement of the drug in the blood, a process known as Therapeutic Drug Monitoring (TDM).

• Target Therapeutic Range: The goal is to maintain the serum concentration between 10 to 15 mcg/mL. Doses are adjusted according to these measured levels, not solely based on symptoms.
• Initial Adult Dose: Typically begins at 300 mg/day total, given in divided doses. The maximum recommended total daily dose is generally 600 mg/day.
• Dose Titration: Doses must be increased cautiously at intervals of no less than three days to allow serum concentrations to reach a steady state before re-testing.

---

Population and Procedural Constraints

• Older Adults: Lower doses are often required; the maximum daily dose is typically not more than 400 mg/day in this population due to reduced clearance.
• Missed Dose: If a scheduled dose is missed, skip the missed dose and take the next dose at the regular scheduled time. Do not double the dose.
• IV Administration: Intravenous infusion rates must not exceed 25 mg/minute when administering a loading dose.

Research evidence / Overview of studies for Теопэк

Evidence for use in Chronic Pain

Research has explored the study of the substance in conditions characterized by physical discomfort, focusing on adult populations diagnosed with chronic non-cancer pain, such as muscle or nerve-related pain. The types of studies applied in this research included short-term randomized trials and observational settings evaluating daily-life functioning.

Studies monitored outcomes related to physical discomfort using patient-reported outcomes describing perceived discomfort, as well as outcomes reflecting daily functioning or activity level. Findings describe patterns observed in the studies over a short duration, such as patterns observed in self-reported pain scores when comparing the group receiving the substance to control groups.

Evidence is limited and certainty remains low. The results apply only to the populations studied, and follow-up durations were limited, meaning that long-term effects are not fully established.

---

Evidence for use in Anxiety Disorders

The substance was studied for its relevance in trials assessing short-term or episodic symptom patterns associated with anxiety disorders. Research examined small populations of adult volunteers diagnosed with conditions involving periods of heightened symptoms, such as generalized or social anxiety.

Studies monitored symptom intensity or variability using standardized, patient-reported scales designed to measure symptom severity. Studies report how symptoms evolved in the observed populations during the brief observation window. Sample sizes were modest and findings were mixed across the limited number of small trials. Data are still emerging, and there is limited information for long-term outcomes, meaning that certainty remains low regarding whether any reported patterns are sustained.

---

What is still uncertain about Теопэк

Data for certain groups remain insufficient. This includes special populations such as older adults, children, or those with significant co-occurring medical conditions. The available research describes what has been observed—and what is still uncertain. Findings were mixed and evidence quality varies across studies, contributing to low certainty. Comparative evidence against other approaches is also lacking or insufficient. The data show patterns related to how symptoms evolved in the observed populations under specific research conditions, but research does not determine whether an individual will respond similarly.

Common questions about Теопэк (FAQ)

Q: What is the route of administration for the extended-release tablet?

According to official product information, the extended-release tablets are intended for oral administration (by mouth). Regulatory administration guidelines state that the tablets should be swallowed whole and are generally not intended to be crushed or chewed, as this helps maintain the intended prolonged-release properties.

Q: How should I dispose of expired or unused Теопэк tablets?

Official guidelines recommend disposing of unused or expired medication through a drug take-back program or an authorized collection site. If a take-back program is unavailable, one option provided in general guidelines is to mix the medication with an undesirable substance, seal it in a container, and discard it in the household trash. It is important not to flush the medication down the toilet.

Q: Does smoking tobacco affect how Теопэк works, and if so, how?

Yes, regulatory documents indicate that smoking tobacco can significantly affect how this medicine works. Smoking causes an increase in the clearance (removal) of Theophylline from the body, which can lead to lower blood levels and potentially reduce its effectiveness. This change is due to the activation of a liver enzyme called CYP1A2.

Q: What is the typical half-life of Theophylline in healthy adults?

The half-life refers to the time required for half of the drug to be eliminated from the body. Official clinical pharmacology data indicates the average elimination half-life of Theophylline in healthy, non-smoking adults is approximately 8 hours. It is important to know that this rate can vary widely depending on factors like age, smoking status, and other health conditions.

Q: Can Теопэк be used to treat acute asthma attacks?

Theophylline extended-release formulations are primarily intended for the long-term maintenance treatment of chronic airway conditions. Regulatory information indicates that this formulation may not be the optimal treatment approach for sudden, acute breathing difficulties, for which other therapies are often preferred.

Q: What is the appearance of the Теопэк extended-release tablet (e.g., color, size, markings)?

Official drug descriptions detail that the active substance, Theophylline, is a white, crystalline powder. Specific details regarding the appearance of the final tablet form, such as its color or imprint markings, are determined by the manufacturer and are typically found within the product’s patient information leaflet.

Q: Should I stop taking Теопэк immediately if I experience nausea and vomiting?

Regulatory warnings indicate that symptoms consistent with potential toxicity, such as repetitive vomiting or severe nausea, may require doses of the medication to be temporarily withheld. Because this situation involves risk, official information stresses the need to consult a healthcare professional immediately.

Storage and Handling Requirements

Labeled Storage Temperature	Controlled Room Temperature: 20 C to 25 C (68 F to 77 F). Brief excursions are permitted between 15 C and 30 C (59 F and 86 F).
Environmental Protection	Store away from excessive heat and moisture. Protection from light is also required.
Container Rule	The medication must be kept in a tightly closed container to preserve its strength and purity.
Child Safety	The product must be stored out of the reach of children to prevent accidental ingestion.

Official Disposal Instructions

Disposal Method	Guidance for Discarding Unused or Expired Product
Preferred Option	Utilize a drug take-back program or an authorized collection site.
Household Alternative	If a take-back program is unavailable, mix the medicine with an unappealing substance (e.g., dirt, coffee grounds), seal the mixture in a bag, and discard in the trash.
Environmental Warning	Do not flush the medication down the toilet or pour it into a drain.

The regulatory profile strictly mandates storage within a defined room temperature range and requires protection from moisture and heat to maintain the stability of the prolonged-release tablet. Official guidelines recommend using a drug take-back program for disposal, or securely mixing the product with an undesirable material before discarding in household trash, rather than disposing of it through wastewater.